Hirano M, Arase H, Arase-Fukushi N, Ogasawara K, Iwabuchi K, Miyazaki T, Good R A, Onoé K
Institute of Immunological Science, Hokkaido University, Sapporo, Japan.
Cell Immunol. 1993 Oct 1;151(1):118-32. doi: 10.1006/cimm.1993.1226.
Reconstitution of lymphoid tissues under the influence of subclinical graft versus host reaction (GVHR) has been investigated. Lethally irradiated AKR mice were reconstituted with B10 bone marrow (BM) cells which had been treated with anti-Thy-1 antibody alone without complement (GVHR chimera). Their immunological reconstitution was analyzed and compared with that of AKR recipients which had been reconstituted with B10 BM cells treated with anti-Thy-1 antibody plus complement (control chimera). One hundred percent of both chimeras survived more than 100 days without showing clinical signs of GVHR. However, full donor chimerism was accomplished at an early stage after reconstitution in the former GVHR chimeras, whereas a substantial number of recipient T cells persisted in control chimeras for the entire observation period. When reconstitution of various lymphoid tissues was compared between control and GVHR chimeras, no difference in the reconstitution of the thymus and spleen was noted. By contrast, the cellularity of peripheral lymph nodes in GVHR chimeras was regularly considerably lower than that of the control chimeras. The apparent insufficiency of lymph node reconstitution appeared to be attributable to the impairment of lymph node structure itself which may be involved in lymphocyte homing. Furthermore, clonal deletion of V beta 6+ T cells which are reactive to recipient (Mls-1a) antigens was abrogated in the GVHR chimeras but was normally induced in the more completely T cell-depleted control chimeras. This abrogation of clonal deletion of V beta 6+ T cells appeared to result from the early disappearance of recipient T cells in these chimeras. Thus, it appeared that donor T cells in the BM that survive anti-Thy-1 treatment in vitro plus subsequent BM transplantation induced a subclinical level GVHR which contributed to the full donor chimerism as well as abrogation of clonal elimination of V beta 6+ donor T cells. Indeed, inoculation of CD8+ T cells along with the transplantation of the T cell-depleted BM cells (anti-Thy-1 plus C-treated cells) from donor mice into the AKR recipients was also shown to induce a similar state in the recipients.
已对亚临床移植物抗宿主反应(GVHR)影响下淋巴组织的重建进行了研究。对接受致死剂量照射的AKR小鼠,用仅经抗Thy - 1抗体处理而无补体的B10骨髓(BM)细胞进行重建(GVHR嵌合体)。分析了它们的免疫重建情况,并与用经抗Thy - 1抗体加补体处理的B10 BM细胞进行重建的AKR受体(对照嵌合体)的免疫重建情况进行了比较。两种嵌合体的100%均存活超过100天,未表现出GVHR的临床症状。然而,在前述GVHR嵌合体中,重建后早期即实现了完全供体嵌合,而在对照嵌合体中,在整个观察期内仍有相当数量的受体T细胞持续存在。当比较对照嵌合体和GVHR嵌合体中各种淋巴组织的重建情况时,胸腺和脾脏的重建未发现差异。相比之下,GVHR嵌合体中外周淋巴结的细胞数量通常明显低于对照嵌合体。淋巴结重建明显不足似乎归因于淋巴结结构本身的损伤,这可能与淋巴细胞归巢有关。此外,对受体(Mls - 1a)抗原具有反应性的Vβ6 + T细胞的克隆缺失在GVHR嵌合体中被废除,但在T细胞耗竭更彻底的对照嵌合体中正常诱导。Vβ6 + T细胞克隆缺失的这种废除似乎是由于这些嵌合体中受体T细胞的早期消失所致。因此,似乎体外经抗Thy - 1处理后存活的BM中的供体T细胞以及随后的BM移植诱导了亚临床水平的GVHR,这有助于实现完全供体嵌合以及废除Vβ6 +供体T细胞的克隆消除。实际上,将CD8 + T细胞与来自供体小鼠的T细胞耗竭的BM细胞(抗Thy - 1加C处理的细胞)一起移植到AKR受体中,也显示能在受体中诱导类似状态。